Sartorius edges up after Q3 earnings beats

** Shares in Sartorius SATG.DE rise 2.4% after the biopharma supplier reported better-than-expected Q3 revenue, adjusted EBITDA

** The German company posted quarterly revenue of €926 million ($1.04 billion), with adjusted EBITDA of €280 million, which both exceeded Vara consensus expectations of €899 million and €269 million respectively

** "Sartorius delivered a strong third quarter," Jefferies says

** The stock, which has gained a fifth in value since mid-September, tops Germany's midcap index .MDAXI

** Its French unit Stedim Biotech STDM.PA shares also rise about 2%, being the second-best performer

** Sartorius AG preferential shares are up 4.2%

($1 = 0.8896 euros)